Jack Henry & Associates Inc: Form 10-Q for the period ended Dec 31, 2023
Filed with the SEC on Feb 8, 2024 and accepted by EDGAR at Feb 8, 2024, 16:50 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-10-01 to 2023-12-31 | $545.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-07-01 to 2023-12-31 | $1.12bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-10-01 to 2023-12-31 | $321.0m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2023-07-01 to 2023-12-31 | $644.0m | us-gaap:CostOfRevenue |
| Research and development | 3 months2023-10-01 to 2023-12-31 | $35.5m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-07-01 to 2023-12-31 | $72.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2023-10-01 to 2023-12-31 | $70.3m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2023-07-01 to 2023-12-31 | $149.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-10-01 to 2023-12-31 | $119.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-07-01 to 2023-12-31 | $251.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-10-01 to 2023-12-31 | $3.9m | us-gaap:InterestExpense |
| Interest expense | 6 months2023-07-01 to 2023-12-31 | $8.1m | us-gaap:InterestExpense |
| Income tax | 3 months2023-10-01 to 2023-12-31 | $28.3m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-07-01 to 2023-12-31 | $59.8m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-10-01 to 2023-12-31 | $92.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-07-01 to 2023-12-31 | $193.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-10-01 to 2023-12-31 | $1.26 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-07-01 to 2023-12-31 | $2.65 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-10-01 to 2023-12-31 | $1.26 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-07-01 to 2023-12-31 | $2.66 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-10-01 to 2023-12-31 | 72,984,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-07-01 to 2023-12-31 | 72,999,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-07-01 to 2023-12-31 | $238.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-07-01 to 2023-12-31 | $24.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2023-07-01 to 2023-12-31 | $75.7m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2023-07-01 to 2023-12-31 | $20.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-12-31 | $26.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-12-31 | $554.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-12-31 | $2.75bn | us-gaap:Assets |
| Current liabilities | At period end2023-12-31 | $404.0m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-12-31 | $1.03bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-12-31 | $1.72bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000779152-24-000018. Last ingested by Listed: Nov 6, 2026, 14:01 ET. Listed shows no prices and gives no investment advice.